Erin Longbrake MD, PhDAssociate Professor of Neurology; Associate Director, Multiple Sclerosis Fellowship Program, Departments of Neurology and Immunobiology, Yale School of Medicine, New Haven, Connecticut
Dr. Longbrake is an associate professor in the Department of Neurology. She graduated summa cum laude from Cedarville University in 1998, then earned combined MD/PhD degrees at the Ohio State University. Her dissertation research focused on the neuro-immune response to traumatic spinal cord injuries. Dr. Longbrake then completed her neurology residency at Washington University in St. Louis. From 2013-2016, Dr. Longbrake was a Sylvia Lawry fellow of the National MS Society. During her fellowship, she was involved in numerous MS clinical trials and focused her research on better understanding the effects of modern MS disease modifying drugs. Dr. Longbrake is a member of the Alpha Omega Alpha Society and the American Academy of Neurology. She joined the Yale faculty in 2016.
DisclosuresDr. Longbrake has received honoraria for consulting for: Genentech, Celegene, Biogen, EMD Serono, Genzyme, Teva.
Recent Contributions to PracticeUpdate:
- Understanding Who Benefits Most From Cognitive Rehabilitation for MS
- Two Fingolimod Doses vs Glatiramer Acetate for Relapsing-Remitting MS
- Ofatumumab vs Teriflunomide in MS
- Effect of Nonmyeloablative HSCT vs Continued Disease-Modifying Therapy on Disease Progression in Relapsing–Remitting MS
- Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
- Diagnosis of Multiple Sclerosis: 2017 Revisions of the McDonald Criteria